Status:
UNKNOWN
Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma.
Lead Sponsor:
Puressentiel
Conditions:
Asthma, Allergic
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The main objective of this study is to evaluate, in real life, the efficacy of prolonged use (6 months) of Puressentiel Air Purifying Spray with 41 essential oils on the control of allergy-induced ast...
Detailed Description
At the inclusion visit (V1), the number of exacerbations requiring oral corticosteroids, and asthma treatments (base and rescue medication) during the previous 12 months are collected. An Asthma Cont...
Eligibility Criteria
Inclusion
- • Mild to moderate asthma patients with or without rhinitis who were diagnosed with asthma at least one year beforehand. At least partially controlled (16≥ACT≥23)
- Patients who are allergic to one allergen per year and/or season (proof of prick tests or specific IgE).
- Patients who are over 18 years old.
- Patients who have read and signed the informed consent form
- Patients who are affiliated to the social security regime
Exclusion
- • Patients who have had a viral infection in the month prior to inclusion
- Patients with uncontrolled asthma.
- Pregnant or breastfeeding women.
- People with a history of seizure disorders, or epilepsy
- People with allergies to any of the components of the product
- Patients with comprehension difficulties
- Patients who cannot be monitored throughout the entire period
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05352126
Start Date
May 1 2022
End Date
March 1 2024
Last Update
April 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.